Comfort And Care Dentistry Of Stanley Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 510 Highway 27 South, Stanley, NC 28164 Phone: 704-263-4646 |
Eric Weed Dds Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 510 S Highway 27, Stanley, NC 28164 Phone: 704-263-4646 |
Ronald M Cox Dds Pa Dentist Medicare: Not Enrolled in Medicare Practice Location: 115 E College Street, Stanley, NC 28164 Phone: 704-263-8845 Fax: 704-263-8184 |
Londry & Modlin Iv Dds Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6573 Bob White Trl, Stanley, NC 28164 Phone: 704-827-4396 |
Warren F Hoyle Dds Pa Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6573 Bob White Trail, Stanley, NC 28164 Phone: 704-827-4396 Fax: 704-827-3996 |
News Archive
Immune cells that would normally die in healthy people accumulate in bodies of patients who have lupus and contribute to the disease, according to new Saint Louis University research published in the Feb. 15 issue of Immunity.
A new preprint research paper posted to the bioRxiv server reports the development of highly effective neutralizing nanobodies targeting the viral receptor-binding domain (RBD), thus disrupting its engagement with the host cell angiotensin-converting enzyme 2 (ACE2) receptor.
Long-term supplementation with dietary antioxidants has beneficial effects on sugar and fat metabolism, blood pressure and arterial flexibility in patients with multiple cardiovascular risk factors. Researchers writing in BioMed Central's open access journal Nutrition and Metabolism report these positive results in a randomized controlled trial of combined vitamin C, vitamin E, coenzyme Q10 and selenium capsules.
Several news organizations report on new taxes in the Senate health bill and how they differ from those in the House-passed measure.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.
› Verified 8 days ago